<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5114462</article-id><article-id pub-id-type="doi">10.3389/fimmu.2016.00482</article-id><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Immunization Strategies against <italic>Piscirickettsia salmonis</italic> Infections: Review of Vaccination Approaches and Modalities and Their Associated Immune Response Profiles</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Evensen</surname><given-names>&#x000d8;ystein</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/198285"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Faculty of Veterinary Medicine and Biosciences, Norwegian University of Life Sciences</institution>, <addr-line>Oslo</addr-line>, <country>Norway</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Swapan K. Ghosh, Indiana State University, USA</p></fn><fn fn-type="edited-by"><p>Reviewed by: Paola Massari, Tufts University School of Medicine, USA; Unni Grimholt, Norwegian Veterinary Institute, Norway</p></fn><corresp content-type="corresp" id="cor1">*Correspondence: &#x000d8;ystein Evensen, <email>oystein.evensen@nmbu.no</email></corresp><fn fn-type="other" id="fn002"><p>Specialty section: This article was submitted to Immunotherapies and Vaccines, a section of the journal Frontiers in Immunology</p></fn></author-notes><pub-date pub-type="epub"><day>18</day><month>11</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>7</volume><elocation-id>482</elocation-id><history><date date-type="received"><day>22</day><month>7</month><year>2016</year></date><date date-type="accepted"><day>20</day><month>10</month><year>2016</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2016 Evensen.</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Evensen</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Salmonid rickettsial septicemia (SRS) is a serious, infectious disease in Chilean salmon farming caused by <italic>Piscirickettsia salmonis</italic>, causing heavy losses to the salmonid industry. <italic>P. salmonis</italic> belongs to the <italic>Gammaproteobacteria</italic>, order <italic>Thiotrichales</italic>. SRS was first described in Chile in 1989, and infection with <italic>P. salmonis</italic> has since been described from a high number of fish species and in several geographic regions globally. <italic>P. salmonis</italic> infection of salmonids causes multifocal, necrotic areas of internal organs such as liver, kidney, and spleen. Histologically and immunologically, the tissue response is the formation of granulomas, often with central suppuration. The exact sequence of infection is not known, but bacteria likely gain access to internal organs through mucosal surfaces and when infected, fish carry bacteria in macrophages. It has not been fully determined if the bacterium resides in the cytosol or &#x0201c;hide&#x0201d; within vesicular structures intracellularly, although there are indications that <italic>in vitro</italic> infection results in actin reorganization and formation of actin-coated vesicle within which the bacterium resides. Protection against lethal challenge is well documented in lab scale experiments, but protection from vaccination has proven more difficult to attain long term under field conditions. Current vaccination protocols include whole cell, inactivated and adjuvanted vaccines for injection for primary immunization followed by oral boost where timing of boost delivery is followed by measuring circulating antibody levels against the pathogen. Documentation also exist that there is correlation between antibody titers and protection against mortality. Future vaccination regimes will likely also include live-attenuated vaccines or other technologies such as DNA vaccination. So far, there is no documentation available for live vaccines and, for DNA vaccines, studies have been unsuccessful under laboratory conditions.</p></abstract><kwd-group><kwd><italic>Piscirickettsia salmonis</italic></kwd><kwd>immunity</kwd><kwd>vaccination</kwd><kwd>modalities</kwd><kwd>efficacy</kwd></kwd-group><funding-group><award-group><funding-source id="cn01">European Commission<named-content content-type="fundref-id">10.13039/501100000780</named-content></funding-source><award-id rid="cn01">TARGETFISH, grant no. 311993</award-id></award-group></funding-group><counts><fig-count count="5"/><table-count count="3"/><equation-count count="0"/><ref-count count="76"/><page-count count="9"/><word-count count="7141"/></counts></article-meta></front><body><sec sec-type="introduction" id="S1"><title>Introduction</title><p>Salmonid rickettsial septicemia (SRS) was first observed in Chile in 1989 (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>), and the etiology of the disease was not understood at the time. It affected market-size Coho salmon (<italic>Onchorhyncus kisutch</italic>), and mortality was observed several weeks after transfer to seawater, reaching up to 90% (<xref rid="B2" ref-type="bibr">2</xref>). It was soon after documented that SRS was caused by infection with <italic>Piscirickettsia salmonis</italic> (<xref rid="B3" ref-type="bibr">3</xref>). Similar disease outbreaks have later been diagnosed in Ireland and Scotland (<xref rid="B4" ref-type="bibr">4</xref>), Norway (<xref rid="B5" ref-type="bibr">5</xref>), and the Atlantic and Pacific coasts of Canada (<xref rid="B6" ref-type="bibr">6</xref>). SRS still causes major losses in salmon farming in Chile, and current annual losses are estimated at 250 million USD and the infection results in a high consumption of antibiotics toward the end of the production cycle (<xref rid="B7" ref-type="bibr">7</xref>). Disease outbreaks are seen in all salmonid species farmed in Chile, Chinook salmon (<italic>Oncorhynchus tshawytscha</italic>), rainbow trout (<italic>Oncorhynchus mykiss</italic>), and Atlantic salmon (<italic>Salmo salar</italic> L.) (<xref rid="B7" ref-type="bibr">7</xref>), and also in other species like Sakura salmon (<italic>Oncorhynchus masou</italic>) (<xref rid="B8" ref-type="bibr">8</xref>), and pink salmon (<italic>Oncorhynchus gorbuscha</italic>) (<xref rid="B1" ref-type="bibr">1</xref>). Infections with <italic>Rickettsia</italic>-like organisms (RLO) have been reported in Mediterranean sea bass (<italic>Dicentrarchus labrax</italic>) (<xref rid="B9" ref-type="bibr">9</xref>), white sea bass (<italic>Atractoscion nobilis</italic>) (<xref rid="B10" ref-type="bibr">10</xref>), grouper (<italic>Epinephelus melanostigma</italic>) (<xref rid="B11" ref-type="bibr">11</xref>), and five species of tilapia (<xref rid="B12" ref-type="bibr">12</xref>). Globally, infections with piscirickettsia and RLO cause severe losses in farmed fish species (Table <xref ref-type="table" rid="T1">1</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p><bold>Overview of host range and geography of reported cases of piscirickettsiosis</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Host</th><th valign="top" align="left" rowspan="1" colspan="1">Geography</th><th valign="top" align="center" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="4" colspan="1"><italic>Salmo salar</italic> &#x02013; Atlantisk laks</td><td align="left" valign="top" rowspan="1" colspan="1">Canada &#x02013; Atlantic ocean</td><td align="center" valign="top" rowspan="4" colspan="1">(<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B66" ref-type="bibr">66</xref>, <xref rid="B67" ref-type="bibr">67</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Norway</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ireland</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Scotland</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>Oncorhynchus gorbuscha &#x02013;</italic> Pink salmon</td><td align="left" valign="top" rowspan="3" colspan="1">Canada &#x02013; Pacific Ocean</td><td align="center" valign="top" rowspan="3" colspan="1">(<xref rid="B68" ref-type="bibr">68</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>Oncorhynchus tshawytscha &#x02013;</italic> Chinook salmon</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>Salmo salar</italic> &#x02013; Atlantic salmon</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>Oncorhynchus kisutch &#x02013;</italic> Coho salmon</td><td align="left" valign="top" rowspan="5" colspan="1">Chile</td><td align="center" valign="top" rowspan="5" colspan="1">(<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B69" ref-type="bibr">69</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>Oncorhynchus mykiss &#x02013;</italic> rainbow trout</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>Oncorhynchus tshawytscha &#x02013;</italic> Chinook salmon</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>Salmo salar</italic> &#x02013; Atlantic salmon</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>Oncorhynchus masou &#x02013;</italic> Masu salmon</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>Atractoscion nobilis</italic> &#x02013; White sea bass</td><td align="left" valign="top" rowspan="1" colspan="1">USA</td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B70" ref-type="bibr">70</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>Epinephelus melanostigma</italic> Grouper</td><td align="left" valign="top" rowspan="1" colspan="1">Taiwan</td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B11" ref-type="bibr">11</xref>)</td></tr></tbody></table></table-wrap></sec><sec id="S2"><title>Etiology</title><p><italic>Piscirickettsia salmonis</italic>, the causative agent of SRS is a Gram-negative, non-motile, non-encapsulated, 0.5&#x02013;1.5&#x02009;&#x003bc;m, intracellular bacterium (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B13" ref-type="bibr">13</xref>) that also grows <italic>in vitro</italic> in cell-free media (<xref rid="B14" ref-type="bibr">14</xref>&#x02013;<xref rid="B16" ref-type="bibr">16</xref>). The bacterium is classified into a new family <italic>Piscirickettsiaceae</italic> in the phylum Proteobacteria, class <italic>Gammaproteobacteria</italic>, and order <italic>Thiotrichales</italic> (<xref rid="B1" ref-type="bibr">1</xref>). It was assigned to a new genus and species <italic>P. salmonis</italic> (<xref rid="B13" ref-type="bibr">13</xref>) with the type strain LF-89 (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B17" ref-type="bibr">17</xref>). It can infect a wide variety of cells lines, such as RTG-2, CHSE-214, RTS-11, and also Sf-21 cells (<xref rid="B18" ref-type="bibr">18</xref>), the latter being an insect cell line that yields high titer (<xref rid="B19" ref-type="bibr">19</xref>). The understanding is that <italic>P. salmonis</italic> replicates within membrane-bound cytoplasmic vacuoles by binary fission (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B20" ref-type="bibr">20</xref>), and <italic>P. salmonis</italic> survives and multiplies in macrophages (<xref rid="B21" ref-type="bibr">21</xref>). In Chile, the disease normally occurs 6&#x02013;12&#x02009;weeks after introduction to seawater, but it is seen throughout the production cycle, resulting in high losses of larger fish. Moribund fish appear dark, anorexic or lethargic, and swim near the surface or edges of the cage (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B17" ref-type="bibr">17</xref>). Some fish may also present skin lesions: hemorrhages, petecchiae, nodules, and ulcers of varying size (<xref rid="B20" ref-type="bibr">20</xref>). Brain infection also occurs and the bacterium is also able to form biofilm under given conditions (<xref rid="B22" ref-type="bibr">22</xref>).</p></sec><sec id="S3"><title>Pathology</title><p>Salmonid rickettsial septicemia in Atlantic salmon is often found with liver changes characterized by multifocal, necrotic areas of the hepatic parenchyma (Figure <xref ref-type="fig" rid="F1">1</xref>). Histologically, the typical tissue response to infection is the formation of granulomas, often with central suppuration and changes are seen in liver, spleen, and kidney (<xref rid="B23" ref-type="bibr">23</xref>), for this reason, the changes have been classified into the broad category of necrosis and inflammation but the principal changes are those of a granulomatous response that are more or less organized (<xref rid="B5" ref-type="bibr">5</xref>). At early stage of infection, granulomas typically consist of macrophages and a large number of neutrophils, often with central necrosis or suppuration (<xref rid="B5" ref-type="bibr">5</xref>) (Figure <xref ref-type="fig" rid="F2">2</xref>). Older granulomas consist of a central necrosis surrounded by connective tissue and fewer inflammatory cells. Perivascular infiltration of macrophages is also a typical finding (<xref rid="B5" ref-type="bibr">5</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Macroscopic changes in Atlantic salmon infected with <italic>Piscrickettsia salmonis</italic></bold>. Note small, gray foci in the liver parenchyma of varying sizes. Gills are found with a grayish surface and the heart is pale (courtesy of Prof. Sandra Bravo, Universidad de Austral, Chile).</p></caption><graphic xlink:href="fimmu-07-00482-g001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>Organization of granulomas</bold>. In general, CD4 and CD8 cells play a role in the granulomatous response. CD4 cells activate the macrophages to enable them to kill the phagocytized pathogen, and CD8 cells will play a role in killing the invading pathogen, likely through killing of infected macrophages. The precise involvement of these cells in the response to <italic>P. salmonis</italic> infection is not understood.</p></caption><graphic xlink:href="fimmu-07-00482-g002"/></fig></sec><sec id="S4"><title>Pathogenesis of Infection</title><p>The exact sequence of infection has not been clarified (<xref rid="B23" ref-type="bibr">23</xref>), but several studies indicate that the bacterium is able to penetrate through intact skin and gills followed by systemic invasion. Invasion through the oral and/or intestinal routes has also been suggested (<xref rid="B24" ref-type="bibr">24</xref>). To what extent the bacterium will survive passage through the stomach and the foregut is not known. Understanding infection routes are important for optimizing immunization protocols and will be discussed later.</p><p>The infection mechanisms at the cellular level are not understood in detail and different alternatives have been proposed: (i) the bacteria locate in cytoplasmic vacuoles in infected cells (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B21" ref-type="bibr">21</xref>), (ii) they are free in the cytoplasm, or (iii) reside outside cells (<xref rid="B17" ref-type="bibr">17</xref>). The localization in the intracellular compartment is tentative (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B21" ref-type="bibr">21</xref>) and has not been conclusively defined, and it is important as to what immune profile would be required for optimal protection. A recent study has shown that the bacterium is dependent on host cell clathrin for infection of macrophages, i.e., chloroquine treatment abolishes the infection (<xref rid="B18" ref-type="bibr">18</xref>). Further to this, results are indicative of the bacterium using actin through a disorganization process. Further, it seems that the bacterium induces <italic>de novo</italic> synthesis (of actin) to form vesicle in cytosolic compartments within which the bacterium resides (<xref rid="B18" ref-type="bibr">18</xref>) rather than using it for movement, as seen with <italic>Listeria monocytogenes</italic> (<xref rid="B25" ref-type="bibr">25</xref>). These responses could also facilitate export of the bacterium from the infected cells; however, this is more of a theory than actually proven experimentally (<xref rid="B18" ref-type="bibr">18</xref>). Further, there is also a possibility that the actin formation is involved in apoptosis induction in infected cells (<xref rid="B26" ref-type="bibr">26</xref>).</p><p>All referred studies have been carried out <italic>in vitro</italic> and translation to <italic>in vivo</italic> conditions carries some uncertainty but the cell types (SHK-1) used for <italic>in vitro</italic> studies derive from Atlantic salmon macrophages (<xref rid="B18" ref-type="bibr">18</xref>), a cell type that is infected by <italic>P.&#x02009;salmonis in vivo</italic> (<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B27" ref-type="bibr">27</xref>). To what extent compartmentalized localization of <italic>P. salmonis</italic> within vesicles would have a bearing on pathogenicity is not known but from a general viewpoint, it might play a role in immune evasion and likely also impact what immune mechanisms will be needed to obtain protective immunity, but this has not been studied in any detail for <italic>P.&#x02009;salmonis</italic>. Immune mechanisms and vaccination strategies will be discussed below.</p><p>Lipid A has also been implicated as playing a role in pathogenesis (<xref rid="B3" ref-type="bibr">3</xref>) and immunity. There has been speculation that the lipid A moiety of <italic>P. salmonis</italic> plays a role in disseminated intravascular coagulation of salmon (<xref rid="B3" ref-type="bibr">3</xref>), but this remains to be proven. It also seems somewhat speculative since salmonids do not express TLR-4 receptors (<xref rid="B28" ref-type="bibr">28</xref>) on any cell types. Further to this, salmonids are insensitive to LPS exposure when administered parentally (<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B29" ref-type="bibr">29</xref>), aligned with the lack of TLR-4 receptors. Doses of 2&#x02013;4&#x02009;mg/ml of partly purified LPS originating from <italic>Escherichia coli</italic> or fish-pathogenic vibrios can be injected intraperitoneally (i.e., vaccinated) without treated individuals developing any signs of circulatory disturbance or clinical symptoms of shock (own observations). Even though it remains to be shown what role, if any, lipid A plays in pathogenesis of SRS and also for immune protection.</p><p>More recently, it has been proposed that <italic>P. salmonis</italic> delivers some of its virulence factors <italic>via</italic> or by outer membrane vesicles (OMVs) to the infected cell (<xref rid="B30" ref-type="bibr">30</xref>). Similar OMV structures were also observed when the bacterium was grown in liquid media and HspP60 (heat shock protein) likely from the bacteria was found in these vesicles (<xref rid="B30" ref-type="bibr">30</xref>) (Figure <xref ref-type="fig" rid="F3">3</xref>).</p><fig id="F3" position="float"><label>Figure 3</label><caption><p><bold>Outer membrane vesicles of <italic>P. salmonis</italic> (Ps)</bold>. Arrows point to membrane-coated vesicles (<xref rid="B30" ref-type="bibr">30</xref>). <bold>(A)</bold> Overview with bacterium (Ps). <bold>(B)</bold> Detail of vesicles (arrows).</p></caption><graphic xlink:href="fimmu-07-00482-g003"/></fig></sec><sec id="S5"><title>Spread of Infection</title><p>During natural infections, <italic>P. salmonis</italic> is transmitted horizontally from fish-to-fish without the need for physical contact (<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B32" ref-type="bibr">32</xref>). No vector or intermediate host has been identified (<xref rid="B17" ref-type="bibr">17</xref>), and during experimental trials, the pathogen has been observed in the milt and celomic fluid of adult brood fish, and also in fry of infected brood fish, suggesting that the bacterium is transmitted vertically (<xref rid="B33" ref-type="bibr">33</xref>). <italic>P. salmonis</italic> has also been reported from outbreaks in freshwater (<xref rid="B1" ref-type="bibr">1</xref>), but is primarily a pathogen that causes clinical disease in sea water.</p></sec><sec id="S6"><title>Disease Prevention</title><p>Disease prevention strategies include reduced stress, improved husbandry practices (lower density, avoid transport/contact between farms, restrict movements of well-boats, fish, and people, separation of year-classes etc.), screening of brood stock, and vaccination. Current disease control practices also include use of antibiotics, since <italic>P. salmonis</italic> have been found susceptible to various antimicrobials. However, reduced sensitivity and increased resistance to penicillin, streptomycin, oxolinic acid, and oxytetracycline have been reported (<xref rid="B12" ref-type="bibr">12</xref>). There are commercial vaccines for intraperitoneal injection available, but these have shown variable results (<xref rid="B34" ref-type="bibr">34</xref>). Vaccinated fish come down with SRS toward the end of the production cycle which causes severe economic losses, i.e., death of fish close to harvest. In Chile, oral vaccines are used as a boost immunization the primary injection vaccination when the antibody titers decline (<xref rid="B34" ref-type="bibr">34</xref>). The different types of vaccines tested and those available commercially and their efficacy profiles are discussed below.</p></sec><sec id="S7"><title>Experimental Vaccines &#x02013; Classical Inactivated Vaccines</title><p>Initial vaccination attempts to vaccinate against SRS were based on whole cell bacterins but with variable results (Table <xref ref-type="table" rid="T2">2</xref>). Trials included vaccine preparations based on unconcentrated or concentrated preparations of formalin-killed <italic>P. salmonis</italic>, and these vaccine preparations gave contradictory results (<xref rid="B35" ref-type="bibr">35</xref>). Different inactivation methods were tested by Birkbeck et al. (<xref rid="B36" ref-type="bibr">36</xref>), and they administered a Scottish isolate of <italic>P. salmonis</italic> (SCO-95A) to Atlantic salmon by intraperitoneal injection, using either heat- or formalin-inactivated bacteria in adjuvant (oil-based adjuvant). They found that both vaccine types, heat- and formalin-inactivated provided significant protection against lethal challenge, RPS (relative percent survival)<xref ref-type="fn" rid="fn1"><sup>1</sup></xref> values of around 70 and 50%, respectively (<xref rid="B36" ref-type="bibr">36</xref>). Challenge was done at approximately 600 degree days (water temperature multiplied by number of days) post-vaccination and long-term protection was not assessed. The nature of the protective antigen was not identified or studied (<xref rid="B19" ref-type="bibr">19</xref>). These authors also studied the importance of the challenge conditions, and they found that experiments conducted at water temperatures of 7.5 to 8.5&#x000b0;C did not result in development of classical SRS, and no mortality was observed under these conditions. When experiments were run at 14&#x000b0;C, high level of mortality was achieved in control groups.</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p><bold>Summary of documented, immunoreactive antigens of <italic>P.&#x02009;salmonis</italic></bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Reference</th><th valign="top" align="left" rowspan="1" colspan="1">Immunoreactive antigens of <italic>Piscirickettsia salmonis</italic></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Kuzyk et al. (<xref rid="B71" ref-type="bibr">71</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">6 immunoreactive Ag (2 carbohydrates). Low humoral response in salmonids infected with these Ag</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Barnes et al. (<xref rid="B72" ref-type="bibr">72</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">6 immunoreactive Ag (2 carbohydrates, 4 proteins). One of the proteins homologous to Hsp60 of <italic>Rickettsia tsutsugamushi</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Jones et al. (<xref rid="B73" ref-type="bibr">73</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">9 protein bands and several non-protein bands were detected by immunoblot. Antigenic homogeneity observed among geographically diverse strains</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Jamett et al. (<xref rid="B74" ref-type="bibr">74</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">Developed and tested 6 monoclonal antibodies against <italic>P. salmonis</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Marshall et al. (<xref rid="B75" ref-type="bibr">75</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">Immunological characterization of Chaperon protein (membrane associated structural component)</td></tr></tbody></table></table-wrap></sec><sec id="S8"><title>Experimental Vaccines &#x02013; Subunit Vaccines</title><p>The use of subunit vaccines is dependent on the protective antigens being identified/known. When available, subunit vaccination strategies will make it possible to fine tune the vaccines to include only antigen(s) important for protection (Table <xref ref-type="table" rid="T2">2</xref>). Kuzyk and coworkers (<xref rid="B37" ref-type="bibr">37</xref>) constructed an expression library from <italic>P.&#x02009;salmonis</italic> and cloned a 17-kDa outer surface lipoprotein (OspA) from the bacterium (Tables <xref ref-type="table" rid="T2">2</xref> and <xref ref-type="table" rid="T3">3</xref>). This was used to immunize Coho salmon that developed strong antibody responses (<xref rid="B38" ref-type="bibr">38</xref>). Fish were subsequently challenged after being vaccinated with the recombinant OspA antigen and a high level of protection was obtained, RPS up to 83%. The protection improved when T cell epitopes from the tetanus toxin and measles virus fusion protein were included in the vaccine (<xref rid="B38" ref-type="bibr">38</xref>). This latter principle would skew the immune response in the direction of T-cell responses. These are the only studies published using this technology, and the vaccine concept has not been brought forward to a commercial product, the reason for which is not known but cost could be an issue.</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p><bold>Summary of published studies on vaccination studies, antigens used, and their obtained efficacy</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Reference</th><th valign="top" align="left" rowspan="1" colspan="1">Antigen</th><th valign="top" align="left" rowspan="1" colspan="1">Vaccine type</th><th valign="top" align="left" rowspan="1" colspan="1">Vaccine efficacy</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Smith et al. (<xref rid="B35" ref-type="bibr">35</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">Killed bacterin</td><td align="left" valign="top" rowspan="1" colspan="1">Formalin inactivated</td><td align="left" valign="top" rowspan="1" colspan="1">Inconsistent results</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Kuzyk et al. (<xref rid="B37" ref-type="bibr">37</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">OspA (outer surface protein A)</td><td align="left" valign="top" rowspan="1" colspan="1">Recombinant subunit vaccine&#x02009;+&#x02009;T cell epitopes</td><td align="left" valign="top" rowspan="1" colspan="1">83% RPS</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Miquel et al. (<xref rid="B48" ref-type="bibr">48</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">Whole genome</td><td align="left" valign="top" rowspan="1" colspan="1">DNA (gene expression library)</td><td align="left" valign="top" rowspan="1" colspan="1">Mortality 80% (inconsistent results)</td></tr><tr><td align="left" valign="top" rowspan="2" colspan="1">Birkbeck et al. (<xref rid="B36" ref-type="bibr">36</xref>)</td><td align="left" valign="top" rowspan="2" colspan="1">Inactivated bacterin (Scottish isolate SCO-95A)</td><td align="left" valign="top" rowspan="2" colspan="1">Heat- or formalin-inactivated</td><td align="left" valign="top" rowspan="1" colspan="1">70.7% RPS</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">49.6% RPS</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Wilhelm et al. (<xref rid="B76" ref-type="bibr">76</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">Hsp60 Hsp70</td><td align="left" valign="top" rowspan="1" colspan="1">Recombinant subunit vaccine</td><td align="left" valign="top" rowspan="1" colspan="1">8% mortality</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Salonius et al. (<xref rid="B47" ref-type="bibr">47</xref>) &#x02013; Commercial vaccine against BKD (Canada)</td><td align="left" valign="top" rowspan="1" colspan="1"><italic>Arthrobacter davidanieli</italic></td><td align="left" valign="top" rowspan="1" colspan="1">Live vaccine</td><td align="left" valign="top" rowspan="1" colspan="1">Laboratory results 2% mortality. Field results 6.7% mortality</td></tr><tr><td align="left" valign="top" rowspan="3" colspan="1">Wilhelm et al. (<xref rid="B39" ref-type="bibr">39</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">(V1) Hsp60/70&#x02009;+&#x02009;FlgG</td><td align="left" valign="top" rowspan="3" colspan="1">Recombinant vaccine including Freund&#x02019;s adjuvant</td><td align="left" valign="top" rowspan="1" colspan="1">(V1) 95&#x02013;94.5% RPS</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">(V2) TbpB&#x02009;+&#x02009;MltB</td><td align="left" valign="top" rowspan="1" colspan="1">(V2) 85%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">(V3) Omp27&#x02009;+&#x02009;FlaA</td><td align="left" valign="top" rowspan="1" colspan="1">(V3) 10.4%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tobar et al. (<xref rid="B56" ref-type="bibr">56</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1">Inactivated bacterin, <italic>P.&#x02009;salmonis</italic> strain PS2C</td><td align="left" valign="top" rowspan="1" colspan="1">Inactivated, whole bacterial antigen formulated in micromatrix for oral delivery or i.p. injection (or combined)</td><td align="left" valign="top" rowspan="1" colspan="1">Onset of immunity by 300 degree days (oral group). IP boosted with oral (1500 degree days), good protection by 1800 degree days post primary immunization (300 degree days post boost)</td></tr></tbody></table></table-wrap><p>In yet another study, Wilhelm et al. (<xref rid="B39" ref-type="bibr">39</xref>) elicited an immune response in Atlantic salmon following intraperitoneal injection of two heat shock proteins cloned from the bacterium, Hsp60 and Hsp70. Mixtures of Hsp60, Hsp70, and the flagellar protein (FlG) were used to immunize fish and this achieved an RPS of 95% (<xref rid="B39" ref-type="bibr">39</xref>). It was also shown that the antibody response persisted for 8&#x02009;months or 2800 degree days post-vaccination (<xref rid="B39" ref-type="bibr">39</xref>), which is encouraging from a commercial standpoint. However, there are few if any follow-up studies based on these antigen combinations, and currently, there are no commercial vaccines available in the market based on the referred antigen combination(s) or other recombinant vaccine preparations. Cost of production is possibly one of the impediments.</p></sec><sec id="S9"><title>Immune Responses Induced from Inactivated/Subunit Vaccines</title><p>Inactivated vaccination protocols will in general elicit an immune response that is biased toward humoral immunity with lesser induction of cell-mediated immune responses (<xref rid="B40" ref-type="bibr">40</xref>), also seen in salmon (<xref rid="B41" ref-type="bibr">41</xref>). Antibodies will exert their biological effects through attachment to surface antigens of the pathogen. This will result in opsonization of bacteria, which again facilitates phagocytosis and intracellular killing by professional phagocytes (<xref rid="B42" ref-type="bibr">42</xref>) also well known in fish (<xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B44" ref-type="bibr">44</xref>). For viruses, neutralization prevents infection of target cells/organs and is an important mode of action (<xref rid="B45" ref-type="bibr">45</xref>). <italic>P. salmonis</italic> is an intracellular pathogen and a relevant question is to what extent circulating antibodies can prevent infection or aid in combating/limiting the spread of infection once established. While the exact pathological sequence is not understood for <italic>P.&#x02009;salmonis</italic> the antibodies could be beneficial during early stages of infection, from port of entry (gills, skin, and gut) and transport to primary or secondary multiplication sites. Then, could circulating antibodies play a role in limiting the spread of bacteria from cell to cell/organ to organ? This would require the bacterium to use an extracellular route of dissemination. It has not been determined in detail if <italic>P. salmonis</italic> spread from cell to cell <italic>via</italic> the extracellular space or use mechanisms similar to what has been described for <italic>L. monocytogenes</italic> that spreads directly from cell to cell, including <italic>via</italic> dying cells (<xref rid="B46" ref-type="bibr">46</xref>). If <italic>P. salmonis</italic> spreads through an extracellular route during early stages of infection, antibodies can be important for opsonization and subsequent killing in professional phagocytes. The fact that protection against disease is seen at early stages after sea transfer/early stage post-vaccination could favor an interpretation of spread through the extracellular space. Further to this, there are good indications of antibody consumption over time, i.e., decline in circulating levels of antibodies as a result of pathogen exposure/infection (<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B47" ref-type="bibr">47</xref>). The approach has been to boost the primary response by oral antigen delivery with the purpose to raise the level of circulating antibodies. This will be discussed more below.</p></sec><sec id="S10"><title>Plasmid Vaccines and Replicating Vaccines</title><p>Given that humoral immune responses are insufficient in providing protection, a rational approach would be to explore vaccine modalities that elicit cell-mediated immune responses. Miquel and coworkers tested out a plasmid vaccine concept or a DNA vaccine (<xref rid="B48" ref-type="bibr">48</xref>). They used fragments of purified DNA from the bacterium based on an expression library that was cloned into the pCMV-Bios vector and subsequently used for immunization. They obtained two colony libraries corresponding to the genome of <italic>P. salmonis</italic>. Plasmid DNA was purified and administered by intramuscular injection into Coho salmon, which was followed by the second injection (plasmid-based boost) 40&#x02009;days after primary immunization. Fish were challenged and only 20% of the vaccinated fish survived. The survivors had decreased bacterial load and the immune response was found specific to <italic>P. salmonis</italic> antigens with no cross-reaction to <italic>Renibacterium salmoninarum</italic> or <italic>Yersinia ruckeri</italic> (<xref rid="B48" ref-type="bibr">48</xref>). Such low level of protection would not be viable as a commercial product and there are currently no plasmid-based SRS vaccines available in the market.</p><p>There are no published studies documenting effect of live-attenuated vaccines, i.e., using attenuated strains of <italic>P. salmonis</italic>. There is one study based on immunization of salmon with live (replicating) <italic>Arthrobacter davidanieli</italic> that showed promising results in terms of increased survival in immunized and challenged Coho salmon compared to controls (<xref rid="B47" ref-type="bibr">47</xref>). This was also tested under field conditions with improved survival. The assumption is that the <italic>Arthrobacter</italic> species share antigens with <italic>P. salmonis</italic> and thus elicit cross reactive antibodies and/or immune effector T cells, but there are no published studies to support this notion. Attenuated vaccine strategies might be interesting alternatives to the inactivated vaccines given the nature of the infection (intracellular) and thus the need for cell-mediated immune responses (<xref rid="B49" ref-type="bibr">49</xref>). Recently, it was announced that a live-attenuated vaccine against SRS will be available in the Chilean market this year (<xref rid="B50" ref-type="bibr">50</xref>), but so far, there are no scientific reports to support the potential effect of the vaccine.</p></sec><sec id="S11"><title>Immune Responses Induced by DNA and Replicating Vaccines</title><p>The immune responses elicited by DNA vaccines and replicating vaccines are biased toward cell-mediated immunity (<xref rid="B49" ref-type="bibr">49</xref>) (Figure <xref ref-type="fig" rid="F4">4</xref>). DNA vaccines elicit bias toward Th1 immunity, i.e., CD4 T cell activation. An attenuated vaccine would give a bias toward CD8 and T cytotoxic responses (<xref rid="B49" ref-type="bibr">49</xref>). It remains to be proven what immune responses actually play the most important role for preventing and/or controlling <italic>P. salmonis</italic> infection in salmonids. While there is no doubt that <italic>P. salmonis</italic> is an intracellular pathogen (<xref rid="B27" ref-type="bibr">27</xref>), it has not been fully documented whether the bacterium resides in endosomes/phagosomes [such as <italic>Mycobacterium</italic> sp. (<xref rid="B51" ref-type="bibr">51</xref>)] or is released from the initial endosome/phagosome to the cytosol, as seen for <italic>L. monocytogenes</italic> (<xref rid="B52" ref-type="bibr">52</xref>, <xref rid="B53" ref-type="bibr">53</xref>). As was mentioned earlier, there are studies indicating that <italic>P. salmonis</italic> induces formation of vesicular structures from actin disorganization and <italic>de novo</italic> synthesis (<xref rid="B18" ref-type="bibr">18</xref>), but it is not known if this is also the site of bacterial growth/division and a source of spread to neighboring cells. The subcellular localization of the bacterium will impact on what type of immune responses would be required for induction of protective immunity. Translating the knowledge from <italic>L. monocytogenes</italic> vaccination studies, it is reasonable to assume that cell-mediated immunity, particularly cytotoxic immune responses, is needed (<xref rid="B53" ref-type="bibr">53</xref>) in addition to strong antibody responses.</p><fig id="F4" position="float"><label>Figure 4</label><caption><p><bold>There are two branches of adaptive immunity that constitute the protective mechanism against infectious diseases: humoral- and cell-mediated immunity</bold>. Humoral immunity is mediated by antibodies that are produced by B cells. It is the main defense mechanism against extracellular pathogens, with secreted antibodies binding to pathogens and assist in their elimination. Cell-mediated immunity is mediated by T cells, with dendritic cells playing key roles in antigen presentation. T cells function by direct killing of cells infected with intracellular pathogens; activating macrophages to kill phagocytized pathogens; or by releasing cytokines to regulate the immune responses (<xref rid="B65" ref-type="bibr">65</xref>).</p></caption><graphic xlink:href="fimmu-07-00482-g004"/></fig></sec><sec id="S12"><title>Commercial Vaccines</title><p>Currently, there are more than 25 different vaccines available in the Chilean market against SRS, extrapolating from a not so recent summary (<xref rid="B54" ref-type="bibr">54</xref>), when all combinations are counted or included. The market is dominated by whole cell vaccines (inactivated) and, currently, several vaccine combinations are available from Virbac-Centrovet (<italic>n</italic>&#x02009;=&#x02009;12) and Pharmaq AS (<italic>n</italic>&#x02009;=&#x02009;5) where both manufacturers provide vaccines for injection (multivalent vaccine for intraperitoneal delivery or monovalent vaccines). These vaccines are oil adjuvanted (water-in-oil emulsions) or live attenuated, and <italic>P. salmonis</italic> is combined with various/different bacterial antigens (for the inactivated vaccines). Other suppliers also sell commercial SRS vaccines in Chile. The experience is that the current vaccine concept confers good short-term protection against disease and mortality, but it has proven inefficient in conferring long-term protection, i.e., the duration of protection is not sufficient to protect the fish throughout their economic life. Virbac-Centrovet has also developed an oral vaccine against SRS designed for boosting after sea transfer (see below) and recently a live-attenuated vaccine became available for the Chilean market (Pharmaq).</p></sec><sec id="S13"><title>Translating Knowledge of Host&#x02013;Pathogen Interactions into Optimized Vaccination Strategies</title><p>It is challenging to translate knowledge of host&#x02013;pathogen interactions and detailed understanding of pathogenesis into improved vaccination strategies. This is particularly true when the pathogenic mechanisms are poorly or insufficiently understood, which to a large extent applies to <italic>P. salmonis</italic> infection in salmon. However, some of the recently gained knowledge of pathogenic events can potentially suggest alternative methods of vaccination/vaccination modalities.</p><p>From the above, it is fair to state that <italic>P. salmonis</italic> infects the fish not only through external surfaces mainly, i.e., skin and gills, but also through the gut mucosa although to a lesser extent (<xref rid="B55" ref-type="bibr">55</xref>). Current vaccination strategies based on non-replicating vaccines will elicit a humoral immune response and to a lesser extent cell-mediated immunity. The kinetics of the antibody response is sparsely studied, but recently, Tobar et al. (<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B56" ref-type="bibr">56</xref>) showed that immunized fish had increased antibody levels up to 800 degree days post-vaccination after which they started to decline (Figure <xref ref-type="fig" rid="F5">5</xref>). There is a successive decline in antibody levels after they have peaked and they reach pre-vaccination levels by 1800&#x02013;1900 degree days post-vaccination. The underlying mechanisms were not studied and are not known in detail but could be due to pathogen exposure and antibody consumption, as has been seen in IPN-vaccinated salmon (<xref rid="B57" ref-type="bibr">57</xref>). In line with such a thinking, the authors showed that declining levels of anti-<italic>P. salmonis</italic> antibodies coincide with increase in SRS-related mortality (<xref rid="B34" ref-type="bibr">34</xref>) indicating that pathogen exposure at least partly explained antibody consumption. Further, oral revaccination increased the circulating antibodies to levels equivalent to or higher than what was achieved from the primary injection vaccine (<xref rid="B34" ref-type="bibr">34</xref>), and even more pronounced when a second oral boost was administered (Figure <xref ref-type="fig" rid="F5">5</xref>). This study is one, among few, showing the circulating antibody levels in salmon show a boost pattern when primary immunization is by the parenteral route (intraperitoneal) and boost by oral delivery. Previously, this has also been shown for IPN vaccines in salmon (<xref rid="B58" ref-type="bibr">58</xref>), and it should be added that for both these studies, IgM was the immunoglobulin isotype measured in serum. Underpinning these observations is a recent study on prime-boost vaccination against infectious salmon anemia virus where the same response pattern was observed (<xref rid="B34" ref-type="bibr">34</xref>). Further, the effect of repeated oral boost has recently been shown for feed-based vaccination of red tilapia (<italic>Oreochromis niloticus x Oreochromis mossambicus</italic>) against streptococcosis (<xref rid="B59" ref-type="bibr">59</xref>). In the referred studies, no attempts were made to measure IgT on mucosal surfaces, but in the study by Chen et al. (<xref rid="B60" ref-type="bibr">60</xref>) transcript levels of IgT in the gut mucosa was measured and increased mRNA expression levels were found. The functional importance is, however, not known. From these studies, the proposed rationale to boost primary immunization by repeated oral boost (<xref rid="B34" ref-type="bibr">34</xref>) seems like a relevant and good proposition, but it remains to be documented from additional field studies. The mechanisms of protection against mortality are not fully understood, although the authors observed that protection against disease coincided with level of antibodies. As has been discussed above, it is not obvious that circulating antibodies will protect against infection or disease development, for the mere reason that <italic>P. salmonis</italic> has an intracellular infection and multiplication strategy. That said, impeding infection efficiency at site(s) of entry, such as gills and skin, and also gut, could play a role in limiting infection success, and it is conceivable that oral boosting will also result in production of IgT in the mucosal lining. It is well known that infection can result in formation of pathogen specific IgT at mucosal surfaces (<xref rid="B61" ref-type="bibr">61</xref>&#x02013;<xref rid="B63" ref-type="bibr">63</xref>). However, to what extent antibodies (IgT) are formed at mucosal surfaces following vaccination and to what extent they actually protect against infection or merely contribute to regulating the commensal flora as has been shown in higher vertebrates (<xref rid="B64" ref-type="bibr">64</xref>) or both, is not fully understood. Nevertheless, the reasoning that injection vaccines (one injection) confer too short protection against mortality (or infection), and applying a concept where fish are monitored for their antibody levels post-vaccination (<xref rid="B34" ref-type="bibr">34</xref>) and then boosted is a good rationale. This concept needs to be further explored, not only for <italic>P. salmonis</italic> infection but also for other diseases/pathogens.</p><fig id="F5" position="float"><label>Figure 5</label><caption><p><bold>Repeated oral immunizations to maintain a long-term protection against SRS</bold>. Salmonids were primary immunized with an injectable mono or polyvalent vaccine against SRS. The arrows at 1700 and 2900 degree days indicate the time-point where first and second oral vaccines were administrated, respectively. Serum samples were obtained at different degree days to determine specific IgM anti-<italic>P. salmonis</italic>. Samples were statistically analyzed by one-way ANOVA &#x02013; Dunnet post-test (150 fish/point) *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05; **<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01; ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 (<xref rid="B34" ref-type="bibr">34</xref>).</p></caption><graphic xlink:href="fimmu-07-00482-g005"/></fig></sec><sec id="S14"><title>Author Contributions</title><p>The author confirms being the sole contributor of this work and approved it for publication.</p></sec><sec id="S15"><title>Conflict of Interest Statement</title><p>The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><fn-group><fn id="fn1"><p><sup>1</sup>Relative percent survival is calculated on the basis of the formula; RPS&#x02009;=&#x02009;[1&#x02009;&#x02212;&#x02009;(mortality in controls/mortality in vaccinates)&#x02009;&#x000d7;&#x02009;100].</p></fn></fn-group><sec id="S16"><title>Funding</title><p>The funding for this work is part from EU Commission project &#x0201c;Targeted disease prophylaxis in European fish farming&#x0201d; &#x02013; TARGETFISH, grant no. 311993.</p></sec><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fryer</surname><given-names>JL</given-names></name><name><surname>Hedrick</surname><given-names>RP</given-names></name></person-group>. <article-title><italic>Piscirickettsia salmonis</italic>: a gram-negative intracellular bacterial pathogen of fish</article-title>. <source>J Fish Dis</source> (<year>2003</year>) <volume>26</volume>(<issue>5</issue>):<fpage>251</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1046/j.1365-2761.2003.00460.x</pub-id><?supplied-pmid 12962234?><pub-id pub-id-type="pmid">12962234</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bravo</surname><given-names>S</given-names></name><name><surname>Campos</surname><given-names>M</given-names></name></person-group>
<article-title>Coho salmon syndrome in Chile</article-title>. <source>Am Fish Soc Fish Health Sect Newsl</source> (<year>1989</year>) <volume>17</volume>:<fpage>3</fpage>.</mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cvitanich</surname><given-names>JD</given-names></name><name><surname>Garate</surname><given-names>ON</given-names></name><name><surname>Smith</surname><given-names>CE</given-names></name></person-group>
<article-title>The isolation of a <italic>Rickettsia</italic>-like organism causing disease and mortality in Chilean salmonids and its confirmation by Koch postulate</article-title>. <source>J Fish Dis</source> (<year>1991</year>) <volume>14</volume>:<fpage>24</fpage><pub-id pub-id-type="doi">10.1111/j.1365-2761.1991.tb00584.x</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodger</surname><given-names>HD</given-names></name><name><surname>Drinan</surname><given-names>EM</given-names></name></person-group>
<article-title>Observation of a <italic>Rickettsia</italic>-like organism in Atlantic salmon, <italic>Salmo salar</italic> L., in Ireland</article-title>. <source>J Fish Dis</source> (<year>1993</year>) <volume>16</volume>(<issue>4</issue>):<fpage>361</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2761.1993.tb00869.x</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olsen</surname><given-names>AB</given-names></name><name><surname>Melby</surname><given-names>HP</given-names></name><name><surname>Speilberg</surname><given-names>L</given-names></name><name><surname>Evensen</surname><given-names>O</given-names></name><name><surname>Hastein</surname><given-names>T</given-names></name></person-group>
<article-title><italic>Piscirickettsia salmonis</italic> infection in Atlantic salmon <italic>Salmo salar</italic> in Norway &#x02013; epidemiological, pathological and microbiological findings</article-title>. <source>Dis Aquat Organ</source> (<year>1997</year>) <volume>31</volume>(<issue>1</issue>):<fpage>35</fpage>&#x02013;<lpage>48</lpage>.<pub-id pub-id-type="doi">10.3354/dao031035</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Evelyn</surname><given-names>TP</given-names></name></person-group>
<article-title>Salmonid rickettsial septicemia</article-title>. In: <person-group person-group-type="editor"><name><surname>Kent</surname><given-names>ML</given-names></name></person-group>, editor. <source>Diseases of Seawater Netpen Reared Salmonid Fishes in the Pacific Northwest</source>, Vol. <volume>116</volume>
<publisher-loc>Nanaimo</publisher-loc>: <publisher-name>Canadian Special Publication of Fisheries and Aquatic Sciences, Department of Fisheries and Oceans</publisher-name> (<year>1992</year>). p. <fpage>18</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henriquez</surname><given-names>P</given-names></name><name><surname>Kaiser</surname><given-names>M</given-names></name><name><surname>Bohle</surname><given-names>H</given-names></name><name><surname>Bustos</surname><given-names>P</given-names></name><name><surname>Mancilla</surname><given-names>M</given-names></name></person-group>
<article-title>Comprehensive antibiotic susceptibility profiling of Chilean <italic>Piscirickettsia salmonis</italic> field isolates</article-title>. <source>J Fish Dis</source> (<year>2016</year>) <volume>39</volume>:<fpage>441</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1111/jfd.12427</pub-id><pub-id pub-id-type="pmid">26660665</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bravo</surname><given-names>C</given-names></name></person-group>
<article-title>Piscirickettsiosis in freshwater</article-title>. <source>Bull Eur Ass Fish Pathol</source> (<year>1994</year>) <volume>14</volume>:<fpage>137</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Athanassopoulou</surname><given-names>F</given-names></name><name><surname>Groman</surname><given-names>D</given-names></name><name><surname>Prapas</surname><given-names>T</given-names></name><name><surname>Sabatakou</surname><given-names>O</given-names></name></person-group>
<article-title>Pathological and epidemiological observations on rickettsiosis in cultured sea bass (<italic>Dicentrarchus labrax</italic> L.) from Greece</article-title>. <source>J Appl Icthyol</source> (<year>2004</year>) <volume>20</volume>(<issue>6</issue>):<fpage>4</fpage><pub-id pub-id-type="doi">10.1111/j.1439-0426.2004.00571.x</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arkush</surname><given-names>KD</given-names></name><name><surname>McBride</surname><given-names>AM</given-names></name><name><surname>Mendonca</surname><given-names>HL</given-names></name><name><surname>Okihiro</surname><given-names>MS</given-names></name><name><surname>Andree</surname><given-names>KB</given-names></name><name><surname>Marshall</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Genetic characterization and experimental pathogenesis of <italic>Piscirickettsia salmonis</italic> isolated from white seabass <italic>Atractoscion nobilis</italic></article-title>. <source>Dis Aquat Organ</source> (<year>2005</year>) <volume>63</volume>(<issue>2&#x02013;3</issue>):<fpage>139</fpage>&#x02013;<lpage>49</lpage>.<pub-id pub-id-type="doi">10.3354/dao063139</pub-id><?supplied-pmid 15819429?><pub-id pub-id-type="pmid">15819429</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>SC</given-names></name><name><surname>Wang</surname><given-names>PC</given-names></name><name><surname>Tung</surname><given-names>MC</given-names></name><name><surname>Thompson</surname><given-names>KD</given-names></name><name><surname>Adams</surname><given-names>A</given-names></name></person-group>
<article-title>A <italic>Piscirickettsia salmonis</italic>-like organism in grouper, <italic>Epinephelus melanostigma</italic>, in Taiwan</article-title>. <source>J Fish Dis</source> (<year>2000</year>) <volume>23</volume>(<issue>6</issue>):<fpage>415</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1046/j.1365-2761.2000.00250.x</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuksel</surname><given-names>SA</given-names></name><name><surname>Thompson</surname><given-names>KD</given-names></name><name><surname>Ellis</surname><given-names>AE</given-names></name><name><surname>Adams</surname><given-names>A</given-names></name></person-group>. <article-title>Improved purification of <italic>Piscirickettsia salmonis</italic> using Percoll gradients</article-title>. <source>J Microbiol Methods</source> (<year>2006</year>) <volume>66</volume>(<issue>2</issue>):<fpage>251</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1016/j.mimet.2005.12.001</pub-id><?supplied-pmid 16434115?><pub-id pub-id-type="pmid">16434115</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fryer</surname><given-names>JL</given-names></name><name><surname>Lannan</surname><given-names>CN</given-names></name><name><surname>Giovannoni</surname><given-names>SJ</given-names></name><name><surname>Wood</surname><given-names>ND</given-names></name></person-group>. <article-title><italic>Piscirickettsia salmonis</italic> gen. nov., sp. nov., the causative agent of an epizootic disease in salmonid fishes</article-title>. <source>Int J Syst Bacteriol</source> (<year>1992</year>) <volume>42</volume>(<issue>1</issue>):<fpage>120</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1099/00207713-42-1-120</pub-id><?supplied-pmid 1371057?><pub-id pub-id-type="pmid">1371057</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mauel</surname><given-names>MJ</given-names></name><name><surname>Ware</surname><given-names>C</given-names></name><name><surname>Smith</surname><given-names>PA</given-names></name></person-group>. <article-title>Culture of <italic>Piscirickettsia salmonis</italic> on enriched blood agar</article-title>. <source>J Vet Diagn Invest</source> (<year>2008</year>) <volume>20</volume>(<issue>2</issue>):<fpage>213</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1177/104063870802000211</pub-id><?supplied-pmid 18319435?><pub-id pub-id-type="pmid">18319435</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mikalsen</surname><given-names>J</given-names></name><name><surname>Skjaervik</surname><given-names>O</given-names></name><name><surname>Wiik-Nielsen</surname><given-names>J</given-names></name><name><surname>Wasmuth</surname><given-names>MA</given-names></name><name><surname>Colquhoun</surname><given-names>DJ</given-names></name></person-group>. <article-title>Agar culture of <italic>Piscirickettsia salmonis</italic>, a serious pathogen of farmed salmonid and marine fish</article-title>. <source>FEMS Microbiol Lett</source> (<year>2008</year>) <volume>278</volume>(<issue>1</issue>):<fpage>43</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1111/j.1574-6968.2007.00977.x</pub-id><?supplied-pmid 18028392?><pub-id pub-id-type="pmid">18028392</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henriquez</surname><given-names>M</given-names></name><name><surname>Gonzalez</surname><given-names>E</given-names></name><name><surname>Marshall</surname><given-names>SH</given-names></name><name><surname>Henriquez</surname><given-names>V</given-names></name><name><surname>Gomez</surname><given-names>FA</given-names></name><name><surname>Martinez</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>A novel liquid medium for the efficient growth of the salmonid pathogen <italic>Piscirickettsia salmonis</italic> and optimization of culture conditions</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>(<issue>9</issue>):<fpage>e71830</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0071830</pub-id><?supplied-pmid 24039723?><pub-id pub-id-type="pmid">24039723</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mauel</surname><given-names>MJ</given-names></name><name><surname>Miller</surname><given-names>DL</given-names></name></person-group>. <article-title>Piscirickettsiosis and piscirickettsiosis-like infections in fish: a review</article-title>. <source>Vet Microbiol</source> (<year>2002</year>) <volume>87</volume>(<issue>4</issue>):<fpage>279</fpage>&#x02013;<lpage>89</lpage>.<pub-id pub-id-type="doi">10.1016/S0378-1135(02)00085-8</pub-id><?supplied-pmid 12069766?><pub-id pub-id-type="pmid">12069766</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramirez</surname><given-names>R</given-names></name><name><surname>Gomez</surname><given-names>FA</given-names></name><name><surname>Marshall</surname><given-names>SH</given-names></name></person-group>. <article-title>The infection process of <italic>Piscirickettsia salmonis</italic> in fish macrophages is dependent upon interaction with host-cell clathrin and actin</article-title>. <source>FEMS Microbiol Lett</source> (<year>2015</year>) <volume>362</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1093/femsle/fnu012</pub-id><?supplied-pmid 25790493?><pub-id pub-id-type="pmid">25790493</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birkbeck</surname><given-names>TH</given-names></name><name><surname>Griffen</surname><given-names>AA</given-names></name><name><surname>Reid</surname><given-names>HI</given-names></name><name><surname>Laidler</surname><given-names>LA</given-names></name><name><surname>Wadsworth</surname><given-names>S</given-names></name></person-group>
<article-title>Growth of <italic>Piscirickettsia salmonis</italic> to high titers in insect tissue culture cells</article-title>. <source>Infect Immun</source> (<year>2004</year>) <volume>72</volume>(<issue>6</issue>):<fpage>3693</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.72.6.3693-3694.2004</pub-id><pub-id pub-id-type="pmid">15155687</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almendras</surname><given-names>FE</given-names></name><name><surname>Jones</surname><given-names>SR</given-names></name><name><surname>Fuentealba</surname><given-names>C</given-names></name><name><surname>Wright</surname><given-names>GM</given-names></name></person-group>. <article-title>In vitro infection of a cell line from <italic>Ictalurus nebulosus</italic> with <italic>Piscirickettsia salmonis</italic></article-title>. <source>Can J Vet Res</source> (<year>1997</year>) <volume>61</volume>(<issue>1</issue>):<fpage>66</fpage>&#x02013;<lpage>8</lpage>.<?supplied-pmid 9008805?><pub-id pub-id-type="pmid">9008805</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname><given-names>UM</given-names></name><name><surname>Bron</surname><given-names>JE</given-names></name><name><surname>Brown</surname><given-names>L</given-names></name><name><surname>Pourahmad</surname><given-names>F</given-names></name><name><surname>Bricknell</surname><given-names>IR</given-names></name><name><surname>Thompson</surname><given-names>KD</given-names></name><etal/></person-group>
<article-title>Survival and replication of <italic>Piscirickettsia salmonis</italic> in rainbow trout head kidney macrophages</article-title>. <source>Fish Shellfish Immunol</source> (<year>2008</year>) <volume>25</volume>(<issue>5</issue>):<fpage>477</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1016/j.fsi.2008.07.005</pub-id><?supplied-pmid 18691656?><pub-id pub-id-type="pmid">18691656</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>SH</given-names></name><name><surname>Gomez</surname><given-names>FA</given-names></name><name><surname>Ramirez</surname><given-names>R</given-names></name><name><surname>Nilo</surname><given-names>L</given-names></name><name><surname>Henriquez</surname><given-names>V</given-names></name></person-group>. <article-title>Biofilm generation by <italic>Piscirickettsia salmonis</italic> under growth stress conditions: a putative in vivo survival/persistence strategy in marine environments</article-title>. <source>Res Microbiol</source> (<year>2012</year>) <volume>163</volume>(<issue>8</issue>):<fpage>557</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1016/j.resmic.2012.08.002</pub-id><?supplied-pmid 22910282?><pub-id pub-id-type="pmid">22910282</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fryer</surname><given-names>JL</given-names></name><name><surname>Mauel</surname><given-names>MJ</given-names></name></person-group>
<article-title>The <italic>Rickettsia</italic>: an emerging group of pathogens in fish</article-title>. <source>Emerg Infect Dis</source> (<year>1997</year>) <volume>3</volume>(<issue>2</issue>):<fpage>137</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="doi">10.3201/eid0302.970206</pub-id><pub-id pub-id-type="pmid">9204294</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>PA</given-names></name><name><surname>Pizarro</surname><given-names>P</given-names></name><name><surname>Ojeda</surname><given-names>P</given-names></name><name><surname>Contreras</surname><given-names>J</given-names></name><name><surname>Oyanedel</surname><given-names>S</given-names></name><name><surname>Larenas</surname><given-names>J</given-names></name></person-group>. <article-title>Routes of entry of <italic>Piscirickettsia salmonis</italic> in rainbow trout <italic>Oncorhynchus mykiss</italic></article-title>. <source>Dis Aquat Organ</source> (<year>1999</year>) <volume>37</volume>(<issue>3</issue>):<fpage>165</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="doi">10.3354/dao037165</pub-id><?supplied-pmid 10546046?><pub-id pub-id-type="pmid">10546046</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Chastellier</surname><given-names>C</given-names></name><name><surname>Berche</surname><given-names>P</given-names></name></person-group>. <article-title>Fate of <italic>Listeria monocytogenes</italic> in murine macrophages: evidence for simultaneous killing and survival of intracellular bacteria</article-title>. <source>Infect Immun</source> (<year>1994</year>) <volume>62</volume>(<issue>2</issue>):<fpage>543</fpage>&#x02013;<lpage>53</lpage>.<?supplied-pmid 8300212?><pub-id pub-id-type="pmid">8300212</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojas</surname><given-names>V</given-names></name><name><surname>Galanti</surname><given-names>N</given-names></name><name><surname>Bols</surname><given-names>NC</given-names></name><name><surname>Jimenez</surname><given-names>V</given-names></name><name><surname>Paredes</surname><given-names>R</given-names></name><name><surname>Marshall</surname><given-names>SH</given-names></name></person-group>. <article-title><italic>Piscirickettsia salmonis</italic> induces apoptosis in macrophages and monocyte-like cells from rainbow trout</article-title>. <source>J Cell Biochem</source> (<year>2010</year>) <volume>110</volume>(<issue>2</issue>):<fpage>468</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="doi">10.1002/jcb.22560</pub-id><?supplied-pmid 20432244?><pub-id pub-id-type="pmid">20432244</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojas</surname><given-names>V</given-names></name><name><surname>Galanti</surname><given-names>N</given-names></name><name><surname>Bols</surname><given-names>NC</given-names></name><name><surname>Marshall</surname><given-names>SH</given-names></name></person-group>. <article-title>Productive infection of <italic>Piscirickettsia salmonis</italic> in macrophages and monocyte-like cells from rainbow trout, a possible survival strategy</article-title>. <source>J Cell Biochem</source> (<year>2009</year>) <volume>108</volume>(<issue>3</issue>):<fpage>631</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1002/jcb.22295</pub-id><?supplied-pmid 19681041?><pub-id pub-id-type="pmid">19681041</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palti</surname><given-names>Y</given-names></name></person-group>. <article-title>Toll-like receptors in bony fish: from genomics to function</article-title>. <source>Dev Comp Immunol</source> (<year>2011</year>) <volume>35</volume>(<issue>12</issue>):<fpage>1263</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1016/j.dci.2011.03.006</pub-id><?supplied-pmid 21414346?><pub-id pub-id-type="pmid">21414346</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacKenzie</surname><given-names>SA</given-names></name><name><surname>Roher</surname><given-names>N</given-names></name><name><surname>Boltana</surname><given-names>S</given-names></name><name><surname>Goetz</surname><given-names>FW</given-names></name></person-group>. <article-title>Peptidoglycan, not endotoxin, is the key mediator of cytokine gene expression induced in rainbow trout macrophages by crude LPS</article-title>. <source>Mol Immunol</source> (<year>2010</year>) <volume>47</volume>(<issue>7&#x02013;8</issue>):<fpage>1450</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.molimm.2010.02.009</pub-id><?supplied-pmid 20304498?><pub-id pub-id-type="pmid">20304498</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliver</surname><given-names>C</given-names></name><name><surname>Valenzuela</surname><given-names>K</given-names></name><name><surname>Hernandez</surname><given-names>M</given-names></name><name><surname>Sandoval</surname><given-names>R</given-names></name><name><surname>Haro</surname><given-names>RE</given-names></name><name><surname>Avendano-Herrera</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Characterization and pathogenic role of outer membrane vesicles produced by the fish pathogen <italic>Piscirickettsia salmonis</italic> under in vitro conditions</article-title>. <source>Vet Microbiol</source> (<year>2016</year>) <volume>184</volume>:<fpage>94</fpage>&#x02013;<lpage>101</lpage>.<pub-id pub-id-type="doi">10.1016/j.vetmic.2015.09.012</pub-id><?supplied-pmid 26854350?><pub-id pub-id-type="pmid">26854350</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>PA</given-names></name><name><surname>Rojas</surname><given-names>ME</given-names></name><name><surname>Guajardo</surname><given-names>A</given-names></name><name><surname>Contreras</surname><given-names>J</given-names></name><name><surname>Morales</surname><given-names>MA</given-names></name><name><surname>Larenas</surname><given-names>J</given-names></name></person-group>. <article-title>Experimental infection of Coho salmon <italic>Oncorhynchus kisutch</italic> by exposure of skin, gills and intestine with <italic>Piscirickettsia salmonis</italic></article-title>. <source>Dis Aquat Organ</source> (<year>2004</year>) <volume>61</volume>(<issue>1&#x02013;2</issue>):<fpage>53</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.3354/dao061053</pub-id><?supplied-pmid 15584410?><pub-id pub-id-type="pmid">15584410</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rees</surname><given-names>EE</given-names></name><name><surname>Ibarra</surname><given-names>R</given-names></name><name><surname>Medina</surname><given-names>M</given-names></name><name><surname>Sanchez</surname><given-names>J</given-names></name><name><surname>Jakob</surname><given-names>E</given-names></name><name><surname>Vanderstichel</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Transmission of <italic>Piscirickettsia salmonis</italic> among salt water salmonid farms in Chile</article-title>. <source>Aquaculture</source> (<year>2014</year>) <volume>428</volume>:<fpage>189</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1016/j.aquaculture.2014.03.031</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larenas</surname><given-names>JJ</given-names></name><name><surname>Bartholomew</surname><given-names>J</given-names></name><name><surname>Troncoso</surname><given-names>O</given-names></name><name><surname>Fernandez</surname><given-names>S</given-names></name><name><surname>Ledezma</surname><given-names>H</given-names></name><name><surname>Sandoval</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Experimental vertical transmission of <italic>Piscirickettsia salmonis</italic> and in vitro study of attachment and mode of entrance into the fish ovum</article-title>. <source>Dis Aquat Organ</source> (<year>2003</year>) <volume>56</volume>(<issue>1</issue>):<fpage>25</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="doi">10.3354/dao056025</pub-id><?supplied-pmid 14524498?><pub-id pub-id-type="pmid">14524498</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tobar</surname><given-names>I</given-names></name><name><surname>Arancibia</surname><given-names>S</given-names></name><name><surname>Torres</surname><given-names>C</given-names></name><name><surname>Vera</surname><given-names>V</given-names></name><name><surname>Soto</surname><given-names>P</given-names></name><name><surname>Carrasco</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Successive oral immunizations against <italic>Piscirickettsia salmonis</italic> and infectious salmon anemia virus are required to maintain a long-term protection in farmed salmonids</article-title>. <source>Front Immunol</source> (<year>2015</year>) <volume>6</volume>:<fpage>244</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2015.00244</pub-id><?supplied-pmid 26074916?><pub-id pub-id-type="pmid">26074916</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>PA</given-names></name><name><surname>Contreras</surname><given-names>JR</given-names></name><name><surname>Larenas</surname><given-names>JJ</given-names></name><name><surname>Aguillon</surname><given-names>JC</given-names></name><name><surname>Garces</surname><given-names>LH</given-names></name><name><surname>Perez</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Immunization with bacterial antigens: piscirickettsiosis</article-title>. <source>Dev Biol Stand</source> (<year>1997</year>) <volume>90</volume>:<fpage>161</fpage>&#x02013;<lpage>6</lpage>.<?supplied-pmid 9270845?><pub-id pub-id-type="pmid">9270845</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birkbeck</surname><given-names>TH</given-names></name><name><surname>Rennie</surname><given-names>S</given-names></name><name><surname>Hunter</surname><given-names>D</given-names></name><name><surname>Laidler</surname><given-names>LA</given-names></name><name><surname>Wadsworth</surname><given-names>S</given-names></name></person-group>
<article-title>Infectivity of a Scottish isolate of <italic>Piscirickettsia salmonis</italic> for Atlantic salmon <italic>Salmo salar</italic> and immune response of salmon to this agent</article-title>. <source>Dis Aquat Organ</source> (<year>2004</year>) <volume>60</volume>(<issue>2</issue>):<fpage>97</fpage>&#x02013;<lpage>103</lpage>.<pub-id pub-id-type="doi">10.3354/dao060097</pub-id><pub-id pub-id-type="pmid">15460853</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuzyk</surname><given-names>MA</given-names></name><name><surname>Burian</surname><given-names>J</given-names></name><name><surname>Thornton</surname><given-names>JC</given-names></name><name><surname>Kay</surname><given-names>WW</given-names></name></person-group>
<article-title>OspA, a lipoprotein antigen of the obligate intracellular bacterial pathogen <italic>Piscirickettsia salmonis</italic></article-title>. <source>J Mol Microbiol Biotechnol</source> (<year>2001</year>) <volume>3</volume>(<issue>1</issue>):<fpage>83</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="pmid">11200233</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuzyk</surname><given-names>MA</given-names></name><name><surname>Burian</surname><given-names>J</given-names></name><name><surname>Machander</surname><given-names>D</given-names></name><name><surname>Dolhaine</surname><given-names>D</given-names></name><name><surname>Cameron</surname><given-names>S</given-names></name><name><surname>Thornton</surname><given-names>JC</given-names></name><etal/></person-group>
<article-title>An efficacious recombinant subunit vaccine against the salmonid rickettsial pathogen <italic>Piscirickettsia salmonis</italic></article-title>. <source>Vaccine</source> (<year>2001</year>) <volume>19</volume>(<issue>17&#x02013;19</issue>):<fpage>2337</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1016/S0264-410X(00)00524-7</pub-id><pub-id pub-id-type="pmid">11257358</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilhelm</surname><given-names>V</given-names></name><name><surname>Miquel</surname><given-names>A</given-names></name><name><surname>Burzio</surname><given-names>LO</given-names></name><name><surname>Rosemblatt</surname><given-names>M</given-names></name><name><surname>Engel</surname><given-names>E</given-names></name><name><surname>Valenzuela</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>A vaccine against the salmonid pathogen <italic>Piscirickettsia salmonis</italic> based on recombinant proteins</article-title>. <source>Vaccine</source> (<year>2006</year>) <volume>24</volume>(<issue>23</issue>):<fpage>5083</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1016/j.vaccine.2006.03.027</pub-id><?supplied-pmid 16697089?><pub-id pub-id-type="pmid">16697089</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>HL</given-names></name><name><surname>Amara</surname><given-names>RR</given-names></name></person-group>. <article-title>T cell vaccines for microbial infections</article-title>. <source>Nat Med</source> (<year>2005</year>) <volume>11</volume>(<issue>4 Suppl</issue>):<fpage>S25</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1038/nm1212</pub-id><?supplied-pmid 15812486?><pub-id pub-id-type="pmid">15812486</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munang&#x02019;andu</surname><given-names>HM</given-names></name><name><surname>Fredriksen</surname><given-names>BN</given-names></name><name><surname>Mutoloki</surname><given-names>S</given-names></name><name><surname>Dalmo</surname><given-names>RA</given-names></name><name><surname>Evensen</surname><given-names>O</given-names></name></person-group>
<article-title>The kinetics of CD4+ and CD8+ T-cell gene expression correlate with protection in Atlantic salmon (<italic>Salmo salar</italic> L) vaccinated against infectious pancreatic necrosis</article-title>. <source>Vaccine</source> (<year>2013</year>) <volume>31</volume>(<issue>15</issue>):<fpage>1956</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1016/j.vaccine.2013.02.008</pub-id><pub-id pub-id-type="pmid">23422142</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leijh</surname><given-names>PC</given-names></name><name><surname>van den Barselaar</surname><given-names>MT</given-names></name><name><surname>van Zwet</surname><given-names>TL</given-names></name><name><surname>Daha</surname><given-names>MR</given-names></name><name><surname>van Furth</surname><given-names>R</given-names></name></person-group>. <article-title>Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes</article-title>. <source>J Clin Invest</source> (<year>1979</year>) <volume>63</volume>(<issue>4</issue>):<fpage>772</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1172/JCI109362</pub-id><?supplied-pmid 374424?><pub-id pub-id-type="pmid">374424</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffin</surname><given-names>BR</given-names></name></person-group>. <article-title>Opsonic effect of rainbow trout (<italic>Salmo gairdneri</italic>) antibody on phagocytosis of <italic>Yersinia ruckeri</italic> by trout leukocytes</article-title>. <source>Dev Comp Immunol</source> (<year>1983</year>) <volume>7</volume>(<issue>2</issue>):<fpage>253</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/0145-305X(83)90006-X</pub-id><?supplied-pmid 6873424?><pub-id pub-id-type="pmid">6873424</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellis</surname><given-names>AE</given-names></name><name><surname>Munro</surname><given-names>ALS</given-names></name><name><surname>Robert</surname><given-names>RJ</given-names></name></person-group>
<article-title>Defense mechanisms in fish. I. A study of the phagocytic system and the fate of intraperitoneally injected particulate material in the plaice (<italic>Pleuronectes platessa</italic>)</article-title>. <source>J Fish Biol</source> (<year>1976</year>) <volume>8</volume>:<fpage>67</fpage>&#x02013;<lpage>78</lpage>.<pub-id pub-id-type="doi">10.1111/j.1095-8649.1976.tb03908.x</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munang Andu</surname><given-names>HM</given-names></name><name><surname>Fredriksen</surname><given-names>BN</given-names></name><name><surname>Mutoloki</surname><given-names>S</given-names></name><name><surname>Dalmo</surname><given-names>RA</given-names></name><name><surname>Evensen</surname><given-names>O</given-names></name></person-group>. <article-title>Antigen dose and humoral immune response correspond with protection for inactivated infectious pancreatic necrosis virus vaccines in Atlantic salmon (<italic>Salmo salar</italic> L)</article-title>. <source>Vet Res</source> (<year>2013</year>) <volume>44</volume>(<issue>1</issue>):<fpage>7</fpage>.<pub-id pub-id-type="doi">10.1186/1297-9716-44-7</pub-id><?supplied-pmid 23398909?><pub-id pub-id-type="pmid">23398909</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czuczman</surname><given-names>MA</given-names></name><name><surname>Fattouh</surname><given-names>R</given-names></name><name><surname>van Rijn</surname><given-names>JM</given-names></name><name><surname>Canadien</surname><given-names>V</given-names></name><name><surname>Osborne</surname><given-names>S</given-names></name><name><surname>Muise</surname><given-names>AM</given-names></name><etal/></person-group>
<article-title><italic>Listeria monocytogenes</italic> exploits efferocytosis to promote cell-to-cell spread</article-title>. <source>Nature</source> (<year>2014</year>) <volume>509</volume>(<issue>7499</issue>):<fpage>230</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1038/nature13168</pub-id><?supplied-pmid 24739967?><pub-id pub-id-type="pmid">24739967</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salonius</surname><given-names>K</given-names></name><name><surname>Siderakis</surname><given-names>C</given-names></name><name><surname>MacKinnon</surname><given-names>AM</given-names></name><name><surname>Griffiths</surname><given-names>SG</given-names></name></person-group>. <article-title>Use of <italic>Arthrobacter davidanieli</italic> as a live vaccine against <italic>Renibacterium salmoninarum</italic> and <italic>Piscirickettsia salmonis</italic> in salmonids</article-title>. <source>Dev Biol (Basel)</source> (<year>2005</year>) <volume>121</volume>:<fpage>189</fpage>&#x02013;<lpage>97</lpage>.<?supplied-pmid 15962482?><pub-id pub-id-type="pmid">15962482</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miquel</surname><given-names>A</given-names></name><name><surname>Muller</surname><given-names>I</given-names></name><name><surname>Ferrer</surname><given-names>P</given-names></name><name><surname>Valenzuela</surname><given-names>PD</given-names></name><name><surname>Burzio</surname><given-names>LO</given-names></name></person-group>. <article-title>Immunoresponse of Coho salmon immunized with a gene expression library from <italic>Piscirickettsia salmonis</italic></article-title>. <source>Biol Res</source> (<year>2003</year>) <volume>36</volume>(<issue>3&#x02013;4</issue>):<fpage>313</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.4067/S0716-97602003000300004</pub-id><?supplied-pmid 14631865?><pub-id pub-id-type="pmid">14631865</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seder</surname><given-names>RA</given-names></name><name><surname>Hill</surname><given-names>AVS</given-names></name></person-group>. <article-title>Vaccines against intracellular infections requiring cellular immunity</article-title>. <source>Nature</source> (<year>2000</year>) <volume>406</volume>(<issue>6797</issue>):<fpage>793</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/35021239</pub-id><?supplied-pmid 10963610?><pub-id pub-id-type="pmid">10963610</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Navarro</surname><given-names>L</given-names></name></person-group>
<source>Chilean Antibiotic Use: Hopes Riding on New Vaccine to Save the Day</source>. (<year>2016</year>). Available from: <uri xlink:type="simple" xlink:href="http://fishfarminginternational.com/chilean-antibiotic-use-hopes-riding-on-new-vaccine-to-save-the-day/">http://fishfarminginternational.com/chilean-antibiotic-use-hopes-riding-on-new-vaccine-to-save-the-day/</uri></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fenton</surname><given-names>MJ</given-names></name><name><surname>Vermeulen</surname><given-names>MW</given-names></name></person-group>
<article-title>Immunopathology of tuberculosis: roles of macrophages and monocytes</article-title>. <source>Infect Immun</source> (<year>1996</year>) <volume>64</volume>(<issue>3</issue>):<fpage>683</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="pmid">8641767</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyahira</surname><given-names>Y</given-names></name><name><surname>Murata</surname><given-names>K</given-names></name><name><surname>Rodriguez</surname><given-names>D</given-names></name><name><surname>Rodriguez</surname><given-names>JR</given-names></name><name><surname>Esteban</surname><given-names>M</given-names></name><name><surname>Rodrigues</surname><given-names>MM</given-names></name><etal/></person-group>
<article-title>Quantification of antigen specific CD8+ T cells using an ELISPOT assay</article-title>. <source>J Immunol Methods</source> (<year>1995</year>) <volume>181</volume>(<issue>1</issue>):<fpage>45</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1016/0022-1759(94)00327-S</pub-id><?supplied-pmid 7537312?><pub-id pub-id-type="pmid">7537312</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohamed</surname><given-names>W</given-names></name><name><surname>Sethi</surname><given-names>S</given-names></name><name><surname>Tchatalbachev</surname><given-names>S</given-names></name><name><surname>Darji</surname><given-names>A</given-names></name><name><surname>Chakraborty</surname><given-names>T</given-names></name></person-group>. <article-title>Protective immunity to <italic>Listeria monocytogenes</italic> infection mediated by recombinant <italic>Listeria innocua</italic> harboring the <italic>VGC</italic> locus</article-title>. <source>PLoS One</source> (<year>2012</year>) <volume>7</volume>(<issue>4</issue>):<fpage>e35503</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0035503</pub-id><?supplied-pmid 22536395?><pub-id pub-id-type="pmid">22536395</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bravo</surname><given-names>S</given-names></name><name><surname>Midtlyng</surname><given-names>PJ</given-names></name></person-group>
<article-title>The use of fish vaccines in the Chilean salmon industry 1999&#x02013;2003</article-title>. <source>Aquaculture</source> (<year>2007</year>) <volume>270</volume>(<issue>1&#x02013;4</issue>):<fpage>36</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1016/j.aquaculture.2007.06.017</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>PA</given-names></name><name><surname>Contreras</surname><given-names>JR</given-names></name><name><surname>Rojas</surname><given-names>ME</given-names></name><name><surname>Guajardo</surname><given-names>A</given-names></name><name><surname>Diaz</surname><given-names>S</given-names></name><name><surname>Carbonero</surname><given-names>A</given-names></name></person-group>
<article-title>Infectivity of <italic>Piscirickettsia salmonis</italic> in immersion-bath exposed rainbow trout <italic>Oncorhynchus mykiss</italic> (Walbaum) fry</article-title>. <source>J Fish Dis</source> (<year>2015</year>) <volume>38</volume>(<issue>8</issue>):<fpage>765</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1111/jfd.12288</pub-id><pub-id pub-id-type="pmid">25168060</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tobar</surname><given-names>JA</given-names></name><name><surname>Jerez</surname><given-names>S</given-names></name><name><surname>Caruffo</surname><given-names>M</given-names></name><name><surname>Bravo</surname><given-names>C</given-names></name><name><surname>Contreras</surname><given-names>F</given-names></name><name><surname>Bucarey</surname><given-names>SA</given-names></name><etal/></person-group>
<article-title>Oral vaccination of Atlantic salmon (<italic>Salmo salar</italic>) against salmonid rickettsial septicaemia</article-title>. <source>Vaccine</source> (<year>2011</year>) <volume>29</volume>(<issue>12</issue>):<fpage>2336</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1016/j.vaccine.2010.12.107</pub-id><?supplied-pmid 21219985?><pub-id pub-id-type="pmid">21219985</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munang&#x02019;andu</surname><given-names>HM</given-names></name><name><surname>Fredriksen</surname><given-names>BN</given-names></name><name><surname>Mutoloki</surname><given-names>S</given-names></name><name><surname>Dalmo</surname><given-names>RA</given-names></name><name><surname>Evensen</surname><given-names>O</given-names></name></person-group>
<article-title>Antigen dose and humoral immune response correspond with protection for inactivated infectious pancreatic necrosis virus vaccines in Atlantic salmon (<italic>Salmo salar</italic> L)</article-title>. <source>Vet Res</source> (<year>2013</year>) <volume>44</volume>:<fpage>7</fpage><pub-id pub-id-type="doi">10.1186/1297-9716-44-7</pub-id><pub-id pub-id-type="pmid">23398909</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Evensen</surname><given-names>O</given-names></name><name><surname>Mutoloki</surname><given-names>S</given-names></name></person-group>. <article-title>IPNV antigen uptake and distribution in Atlantic salmon following oral administration</article-title>. <source>Viruses</source> (<year>2015</year>) <volume>7</volume>(<issue>5</issue>):<fpage>2507</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="doi">10.3390/v7052507</pub-id><?supplied-pmid 26008698?><pub-id pub-id-type="pmid">26008698</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ismail</surname><given-names>MS</given-names></name><name><surname>Siti-Zahrah</surname><given-names>A</given-names></name><name><surname>Syafiq</surname><given-names>MR</given-names></name><name><surname>Amal</surname><given-names>MN</given-names></name><name><surname>Firdaus-Nawi</surname><given-names>M</given-names></name><name><surname>Zamri-Saad</surname><given-names>M</given-names></name></person-group>
<article-title>Feed-based vaccination regime against streptococcosis in red tilapia, <italic>Oreochromis niloticus x Oreochromis mossambicus</italic></article-title>. <source>BMC Vet Res</source> (<year>2016</year>) <volume>12</volume>:<fpage>194</fpage><pub-id pub-id-type="doi">10.1186/s12917-016-0834-1</pub-id><pub-id pub-id-type="pmid">27608936</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Klaric</surname><given-names>G</given-names></name><name><surname>Wadsworth</surname><given-names>S</given-names></name><name><surname>Jayasinghe</surname><given-names>S</given-names></name><name><surname>Kuo</surname><given-names>TY</given-names></name><name><surname>Evensen</surname><given-names>O</given-names></name><etal/></person-group>
<article-title>Augmentation of the antibody response of Atlantic salmon by oral administration of alginate-encapsulated IPNV antigens</article-title>. <source>PLoS One</source> (<year>2014</year>) <volume>9</volume>(<issue>10</issue>):<fpage>e109337</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0109337</pub-id><?supplied-pmid 25310804?><pub-id pub-id-type="pmid">25310804</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>YA</given-names></name><name><surname>Salinas</surname><given-names>I</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Parra</surname><given-names>D</given-names></name><name><surname>Bjork</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><etal/></person-group>
<article-title>IgT, a primitive immunoglobulin class specialized in mucosal immunity</article-title>. <source>Nat Immunol</source> (<year>2010</year>) <volume>11</volume>(<issue>9</issue>):<fpage>827</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="doi">10.1038/ni.1913</pub-id><?supplied-pmid 20676094?><pub-id pub-id-type="pmid">20676094</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Parra</surname><given-names>D</given-names></name><name><surname>Gomez</surname><given-names>D</given-names></name><name><surname>Salinas</surname><given-names>I</given-names></name><name><surname>Zhang</surname><given-names>YA</given-names></name><name><surname>von Gersdorff Jorgensen</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Teleost skin, an ancient mucosal surface that elicits gut-like immune responses</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2013</year>) <volume>110</volume>(<issue>32</issue>):<fpage>13097</fpage>&#x02013;<lpage>102</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1304319110</pub-id><?supplied-pmid 23884653?><pub-id pub-id-type="pmid">23884653</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Takizawa</surname><given-names>F</given-names></name><name><surname>Parra</surname><given-names>D</given-names></name><name><surname>Gomez</surname><given-names>D</given-names></name><name><surname>von Gersdorff Jorgensen</surname><given-names>L</given-names></name><name><surname>LaPatra</surname><given-names>SE</given-names></name><etal/></person-group>
<article-title>Mucosal immunoglobulins at respiratory surfaces mark an ancient association that predates the emergence of tetrapods</article-title>. <source>Nat Commun</source> (<year>2016</year>) <volume>7</volume>:<fpage>10728</fpage>.<pub-id pub-id-type="doi">10.1038/ncomms10728</pub-id><?supplied-pmid 26869478?><pub-id pub-id-type="pmid">26869478</pub-id></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macpherson</surname><given-names>AJ</given-names></name><name><surname>McCoy</surname><given-names>KD</given-names></name><name><surname>Johansen</surname><given-names>FE</given-names></name><name><surname>Brandtzaeg</surname><given-names>P</given-names></name></person-group>. <article-title>The immune geography of IgA induction and function</article-title>. <source>Mucosal Immunol</source> (<year>2008</year>) <volume>1</volume>(<issue>1</issue>):<fpage>11</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1038/mi.2007.6</pub-id><?supplied-pmid 19079156?><pub-id pub-id-type="pmid">19079156</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rabb</surname><given-names>H</given-names></name></person-group>. <article-title>The T cell as a bridge between innate and adaptive immune systems: implications for the kidney</article-title>. <source>Kidney Int</source> (<year>2002</year>) <volume>61</volume>(<issue>6</issue>):<fpage>1935</fpage>&#x02013;<lpage>46</lpage>.<pub-id pub-id-type="doi">10.1046/j.1523-1755.2002.00378.x</pub-id><?supplied-pmid 12028434?><pub-id pub-id-type="pmid">12028434</pub-id></mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cusack</surname><given-names>RR</given-names></name><name><surname>Groman</surname><given-names>DB</given-names></name><name><surname>Jones</surname><given-names>SRM</given-names></name></person-group>. <article-title>Rickettsial infection in farmed Atlantic salmon in eastern Canada</article-title>. <source>Can Vet J</source> (<year>2002</year>) <volume>43</volume>(<issue>6</issue>):<fpage>435</fpage>&#x02013;<lpage>40</lpage>.<?supplied-pmid 12058568?><pub-id pub-id-type="pmid">12058568</pub-id></mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reid</surname><given-names>HI</given-names></name><name><surname>Griffen</surname><given-names>AA</given-names></name><name><surname>Birkbeck</surname><given-names>TH</given-names></name></person-group>. <article-title>Isolates of <italic>Piscirickettsia salmonis</italic> from Scotland and Ireland show evidence of clonal diversity</article-title>. <source>Appl Environ Microbiol</source> (<year>2004</year>) <volume>70</volume>(<issue>7</issue>):<fpage>4393</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1128/AEM.70.7.4393-4397.2004</pub-id><?supplied-pmid 15240328?><pub-id pub-id-type="pmid">15240328</pub-id></mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Evelyn</surname><given-names>TPT</given-names></name><name><surname>Kent</surname><given-names>ML</given-names></name><name><surname>Poppe</surname><given-names>TT</given-names></name><name><surname>Bustos</surname><given-names>P</given-names></name></person-group>
<article-title>Bacterial diseases</article-title>. In: <person-group person-group-type="editor"><name><surname>Kent</surname><given-names>ML</given-names></name><name><surname>Poppe</surname><given-names>TT</given-names></name></person-group>, editors. <source>Diseases of Seawater Netpen-Reared Salmonid Fishes</source>. <publisher-loc>Nanaimo, BC</publisher-loc>: <publisher-name>Quadra Printers Ltd.</publisher-name> (<year>1998</year>). p. <fpage>31</fpage>&#x02013;<lpage>4</lpage>.</mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000e8;s</surname><given-names>LH</given-names></name><name><surname>Larenas</surname><given-names>JJ</given-names></name><name><surname>Smith</surname><given-names>PA</given-names></name><name><surname>Sandino</surname><given-names>S</given-names></name><name><surname>Lannan</surname><given-names>CN</given-names></name><name><surname>Fryer</surname><given-names>JL</given-names></name></person-group>
<article-title>Infectivity of a <italic>Rickettsia</italic> isolated from Coho salmon (<italic>Oncorhynchus kisutch</italic>)</article-title>. <source>Dis Aquat Organ</source> (<year>1991</year>) <volume>11</volume>:<fpage>93</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.3354/dao011093</pub-id></mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>MF</given-names></name><name><surname>Yun</surname><given-names>S</given-names></name><name><surname>Marty</surname><given-names>GD</given-names></name><name><surname>McDowell</surname><given-names>TS</given-names></name><name><surname>House</surname><given-names>ML</given-names></name><name><surname>Appersen</surname><given-names>JA</given-names></name><etal/></person-group>
<article-title>A&#x02009;<italic>Piscirickettsia salmonis</italic>-like bacterium associated with mortality of white seabass <italic>Atractoscion nobilis</italic></article-title>. <source>Dis Aquat Organ</source> (<year>2000</year>) <volume>43</volume>(<issue>2</issue>):<fpage>117</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="doi">10.3354/dao043117</pub-id><pub-id pub-id-type="pmid">11145452</pub-id></mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuzyk</surname><given-names>MA</given-names></name><name><surname>Thorton</surname><given-names>JC</given-names></name><name><surname>Kay</surname><given-names>WW</given-names></name></person-group>. <article-title>Antigenic characterization of the salmonid pathogen <italic>Piscirickettsia salmonis</italic></article-title>. <source>Infect Immun</source> (<year>1996</year>) <volume>64</volume>(<issue>12</issue>):<fpage>5205</fpage>&#x02013;<lpage>10</lpage>.<?supplied-pmid 8945567?><pub-id pub-id-type="pmid">8945567</pub-id></mixed-citation></ref><ref id="B72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnes</surname><given-names>MN</given-names></name><name><surname>Landolt</surname><given-names>ML</given-names></name><name><surname>Powell</surname><given-names>DB</given-names></name><name><surname>Winton</surname><given-names>JR</given-names></name></person-group>. <article-title>Purification of <italic>Piscirickettsia salmonis</italic> and partial characterization of antigens</article-title>. <source>Dis Aquat Organ</source> (<year>1998</year>) <volume>33</volume>(<issue>1</issue>):<fpage>33</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.3354/dao033033</pub-id><?supplied-pmid 9678968?><pub-id pub-id-type="pmid">9678968</pub-id></mixed-citation></ref><ref id="B73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>SR</given-names></name><name><surname>Markham</surname><given-names>RJ</given-names></name><name><surname>Groman</surname><given-names>DB</given-names></name><name><surname>Cusack</surname><given-names>RR</given-names></name></person-group>. <article-title>Virulence and antigenic characteristics of a cultured rickettsiales-like organism isolated from farmed Atlantic salmon <italic>Salmo salar</italic> in eastern Canada</article-title>. <source>Dis Aquat Organ</source> (<year>1998</year>) <volume>33</volume>(<issue>1</issue>):<fpage>25</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.3354/dao033025</pub-id><?supplied-pmid 9653456?><pub-id pub-id-type="pmid">9653456</pub-id></mixed-citation></ref><ref id="B74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamett</surname><given-names>A</given-names></name><name><surname>Aguayo</surname><given-names>J</given-names></name><name><surname>Miquel</surname><given-names>A</given-names></name><name><surname>Muller</surname><given-names>I</given-names></name><name><surname>Arriagada</surname><given-names>R</given-names></name><name><surname>Becker</surname><given-names>MI</given-names></name><etal/></person-group>
<article-title>Characteristics of monoclonal antibodies against <italic>Piscirickettsia salmonis</italic></article-title>. <source>J Fish Dis</source> (<year>2001</year>) <volume>24</volume>(<issue>4</issue>):<fpage>205</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1046/j.1365-2761.2001.00285.x</pub-id></mixed-citation></ref><ref id="B75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>SH</given-names></name><name><surname>Conejeros</surname><given-names>P</given-names></name><name><surname>Zahr</surname><given-names>M</given-names></name><name><surname>Olivares</surname><given-names>J</given-names></name><name><surname>Gomez</surname><given-names>F</given-names></name><name><surname>Cataldo</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Immunological characterization of a bacterial protein isolated from salmonid fish naturally infected with <italic>Piscirickettsia salmonis</italic></article-title>. <source>Vaccine</source> (<year>2007</year>) <volume>25</volume>(<issue>11</issue>):<fpage>2095</fpage>&#x02013;<lpage>102</lpage>.<pub-id pub-id-type="doi">10.1016/j.vaccine.2006.11.035</pub-id><?supplied-pmid 17250933?><pub-id pub-id-type="pmid">17250933</pub-id></mixed-citation></ref><ref id="B76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilhelm</surname><given-names>V</given-names></name><name><surname>Soza</surname><given-names>C</given-names></name><name><surname>Martinez</surname><given-names>R</given-names></name><name><surname>Rosemblatt</surname><given-names>M</given-names></name><name><surname>Burzio</surname><given-names>LO</given-names></name><name><surname>Valenzuela</surname><given-names>PD</given-names></name></person-group>. <article-title>Production and immune response of recombinant Hsp60 and Hsp70 from the salmon pathogen <italic>Piscirickettsia salmonis</italic></article-title>. <source>Biol Res</source> (<year>2005</year>) <volume>38</volume>(<issue>1</issue>):<fpage>69</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.4067/S0716-97602005000100009</pub-id><?supplied-pmid 15977412?><pub-id pub-id-type="pmid">15977412</pub-id></mixed-citation></ref></ref-list></back></article>